MichaelClineDO

Physician

Dr. Cline is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Cleveland Clinic - South Pointe Hospital Medical Office Building B
20050 Harvard Ave
Cleveland, OH 44122
Phone+1 216-491-7853

Fax+1 216-636-5892

Michael Cline, DO, is a Gastroenterologist based in Cleveland, OH with experience in procedures such as endoscopy, colonoscopy, gastroparesis, and gastric pacemaker. He completed his residency in Internal Medicine at Mount Carmel Health System and his gastroenterology fellowship at Allegheny Health Network Medical Education Consortium (AGH). Dr. Cline has multiple publications in reputable journals, with some being cited multiple times by other works. He has also been recognized as the Most Compassionate Doctor by the American Registry. His medical education was concluded at the Ohio University Heritage College of Osteopathic Medicine.

Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Gastroenterology, 1993 - 1995
Mount Carmel Health SystemResidency, Internal Medicine, 1990 - 1993
Ohio University Heritage College of Osteopathic Medicine in AthensClass of 1989

PubMed

Endometriosis Is Associated With Higher Healthcare Utilization and Upper Gastrointestinal Symptoms.
Madison Simons, Michael Cline, Ashley Gubbels, Cara King, Anthony Lembo
Clinical Gastroenterology and Hepatology. 2024-10-01
Gastrointestinal Amyloid Screening Study (GASS): is screening for amyloid in the gastrointestinal tract useful?
Rola Khedraki, Joseph El-Roumi, Daniela Allende, Lauren Ives, Ari Garber
Amyloid. 2024-09-01
Scoping review: the social and emotional impacts of gastroparesis.
Madison Simons, Michael Cline
Translational Gastroenterology and Hepatology. 2024-01-01

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 Users with Diabetic Gastroparesis Using GIMOTI®October 28th, 2024